I reckon they panicked. A typical repo’s margin rate is between 8-15%. Look at where Barito groups’ stocks are and how far they’ve plummeted. So, the rumors might be true, although they’ve responded with this.
Everyone is benefiting from AI and chip stocks rally, but only some benefited from uranium, lithium, tungsten, and other rare earth metals rallies and those few are making heaps! So the question is, what will be the next frontier? I'd say biotechnology or life sciences.
@BagusPerdana_@pinkbourbon8898 Ramlie’s skills lean towards corporate finance/corporate development, PE & IB. Luke lebih technical (on the ground) and managerial person. Both ok.
Semangat pahlawan bursa! Kemarin bilang ke temen $IDX mau di bawa ke 6000an kecil, taunya karena technical and macro support.
And thankfully ga kena drawdown $IHSG, tapi round trip 😂.
My outlook remains kalau $IDX mungkin weight di turunin and maintain liga emerging marketnya.
Cheers semangat dan buy the dip?🤣
Semangat pahlawan bursa! Kemarin bilang ke temen $IDX mau di bawa ke 6000an kecil, taunya karena technical and macro support.
And thankfully ga kena drawdown $IHSG, tapi round trip 😂.
My outlook remains kalau $IDX mungkin weight di turunin and maintain liga emerging marketnya.
Cheers semangat dan buy the dip?🤣
Awal tahun ketemu saham $TAPG, di bear market masih bisa perform +46%, not bad.
$TAPG by valuation sangat attractive dan pada waktu itu $TAPG juga salah satu emiten yang constantly di akum foreign tapi masih stagnant. So good bet!
You have no experience.
You’ve never started a company.
You’ve never had a full time job.
Nike is going to kill you.
You’re a kid.
You don’t have technical skills.
You shouldn’t build hardware.
Apple is going to kill you.
You can’t build hardware.
You can’t measure heart rate non-invasively.
Athletes don’t care about recovery.
Under Armour is going to kill you.
It won’t be accurate.
You don’t listen.
You’re an ineffective leader.
You can’t recruit great talent.
You’re going to have to pay every athlete.
You can’t measure sleep non-invasively.
It’s too expensive to research.
Athletes are a small market.
The product costs too much to make.
The product costs too much to sell.
Your valuation is too high.
Consumers aren’t going to want it.
Hardware is too hard.
You should measure steps.
Fitbit is going to kill you.
You can’t build a marketing engine.
You can’t raise enough money.
You need a real CEO.
Google is going to kill you.
You can’t be a subscription.
You can’t build a brand.
You can’t do consumer in Boston.
Your valuation is too high.
You shouldn’t make accessories.
You shouldn’t make apparel.
Lululemon is going to kill you.
You can’t predict Covid.
Stay in your niche.
You are going to run out of money.
You can’t build a health platform.
Amazon is going to kill you.
You can’t measure blood pressure.
You can’t get medical approvals.
The market is too small.
You don’t understand AI.
The market is too competitive.
It won’t work internationally.
The supply chain is too complicated.
You can’t build an AI.
You can’t raise enough money.
It’s too competitive.
Healthcare isn’t going to want it.
…
Just keep going ✌️
Baru dapet chat ini. 2 kemungkinannya adalah bisa jadi tanda IHSG masih belum bottom karena masih pada FOMO atau justru IHSG sebentar lagi rebound karena ada capital flow ke market 😅